Emotra has been informed by a candidate for new director... 211007 - PM - Emotra notifies that candidate for board is no longer available for appointment to the board of NeuraMetrix AB
Today, Emotra reached an agreement with the shareholders of NeuraMetrix, Inc. (“the Sellers”) to acquire all outstanding shares in NeuraMetrix, Inc.... 210831 - PM - Emotra AB has reached conditional agreement to acquire NeuraMetrix
The Board and CEO of Emotra AB (publ) hereby present the interim report for the first six months of 2021. 210820 Interim report Jan- June 2021
I maj 2021 genomförde EMOTRA AB (”Emotra”) en företrädesemission av Units (varje unit innehåller två (2) aktier.... 210712- Emotra- PM - Sista dag för handel i BTU
EDOR test, Emotra’s method for identifying at-risk populations in mental health care, has now secured increased protection... 210707 - Emotra- PM - Emotra is granted patent protection in Canada
An agreement for collaboration has been signed between Kings College in the UK and Emotra. z 210709 - Emotra - PM - Emotra signs agreement with Kings College
Emotra AB (“Emotra” or “the Company”) has completed the Rights Issue of units decided by the Board on April 22, 2021... 20210617 - Emotra- PM - Freferential share issue for underwriters
In the fully underwritten rights issue in Emotra AB (“Emotra” or “the Company”) amounting to appr. 9.5 MSEK... 20210615 - Emotra- PM - Rights issue outcome
Emotra AB (“Emotra” or “the Company”) is proud to announce that Mangold Insight has published an updated analysis... 20210608 - Emotra- PM - CEO interview and analysis from Mangold Insight
After a period of discussions, an agreement for collaboration has been signed between National Institute of Mental Health (NIMH) in USA and Emotra. 210609 - Emotra - PM - Emotra signs agreement with NIMH
